The hormone-receptor-negative/HER-2 positive and TN BC subtypes are the most aggressive forms, so, unsurprisingly, neo-endothelium shows higher PSMA expression in these subtypes than in less aggressive variants [24]. This evidence concerns the gene NR4A1 and breast cancer.